Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lanni

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Oxidative Medicine and Cellular Longevity|May 5, 2018
Characterization of the Antioxidant Effects of <i>γ</i>-Oryzanol: Involvement of the Nrf2 PathwayW Rungratanawanich, G Abate, M M Serafini, et al.
Neuroscience|June 15, 2007
Soluble amyloid beta1-42 reduces dopamine levels in rat prefrontal cortex: relationship to nitric oxideL Trabace, K M Kendrick, S Castrignanò, et al.
International Journal of Immunopharmacology|April 1, 1992
The discovery and development of zileuton: an orally active 5-lipoxygenase inhibitorR L Bell, P R Young, D Albert, et al.
Annals of the New York Academy of Sciences|November 30, 1993
Preclinical and clinical activity of zileuton and A-78773R L Bell, C Lanni, P E Malo, et al.
Journal of Lipid Mediators|March 1, 1993
A-78773: a selective, potent 5-lipoxygenase inhibitorR L Bell, D W Brooks, P R Young, et al.
American Journal of Respiratory and Critical Care Medicine|April 14, 2000
Anti-inflammatory effects of zileuton in a subpopulation of allergic asthmaticsJ D Hasday, S S Meltzer, W C Moore, et al.
Cell Death & Disease|February 9, 2013
Conformational altered p53 affects neuronal function: relevance for the response to toxic insult and growth-associated protein 43 expressionL Buizza, C Prandelli, S A Bonini, et al.
Agents and Actions|March 1, 1993
The properties of A-69412: a small hydrophilic 5-lipoxygenase inhibitorR L Bell, J Bouska, P R Young, et al.
Annals of the New York Academy of Sciences|November 15, 1994
Stereoselective metabolism of the 5-lipoxygenase inhibitor A-78773G W Carter, R L Bell, K Marsh, et al.
Oxidative Medicine and Cellular Longevity|February 17, 2016
Mitochondrial Alterations in Peripheral Mononuclear Blood Cells from Alzheimer's Disease and Mild Cognitive Impairment PatientsA Delbarba, G Abate, C Prandelli, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Oxidative Medicine and Cellular Longevity|May 5, 2018
Characterization of the Antioxidant Effects of <i>γ</i>-Oryzanol: Involvement of the Nrf2 PathwayW Rungratanawanich, G Abate, M M Serafini, et al.
Neuroscience|June 15, 2007
Soluble amyloid beta1-42 reduces dopamine levels in rat prefrontal cortex: relationship to nitric oxideL Trabace, K M Kendrick, S Castrignanò, et al.
International Journal of Immunopharmacology|April 1, 1992
The discovery and development of zileuton: an orally active 5-lipoxygenase inhibitorR L Bell, P R Young, D Albert, et al.
Annals of the New York Academy of Sciences|November 30, 1993
Preclinical and clinical activity of zileuton and A-78773R L Bell, C Lanni, P E Malo, et al.
Journal of Lipid Mediators|March 1, 1993
A-78773: a selective, potent 5-lipoxygenase inhibitorR L Bell, D W Brooks, P R Young, et al.
American Journal of Respiratory and Critical Care Medicine|April 14, 2000
Anti-inflammatory effects of zileuton in a subpopulation of allergic asthmaticsJ D Hasday, S S Meltzer, W C Moore, et al.
Cell Death & Disease|February 9, 2013
Conformational altered p53 affects neuronal function: relevance for the response to toxic insult and growth-associated protein 43 expressionL Buizza, C Prandelli, S A Bonini, et al.
Agents and Actions|March 1, 1993
The properties of A-69412: a small hydrophilic 5-lipoxygenase inhibitorR L Bell, J Bouska, P R Young, et al.
Annals of the New York Academy of Sciences|November 15, 1994
Stereoselective metabolism of the 5-lipoxygenase inhibitor A-78773G W Carter, R L Bell, K Marsh, et al.
Oxidative Medicine and Cellular Longevity|February 17, 2016
Mitochondrial Alterations in Peripheral Mononuclear Blood Cells from Alzheimer's Disease and Mild Cognitive Impairment PatientsA Delbarba, G Abate, C Prandelli, et al.
Pageof 4